Obiltoxaximab OverviewObiltoxaximab, sold under the brand name Anthim, is a monoclonal antibody medication designed for the treatment of exposure to Bacillus anthracis spores (etiologic agent of anthrax). This drug was developed by Elusys Therapeutics, Inc. Contents 1 Society and culture 1.1 Legal status 2 References 3 External links Society and culture Legal status On 17 September 2020, the Committee for Medicinal Products for...
Read more Obiltoxaximab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Obiltoxaximab
Recent Obiltoxaximab Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 600mg/6ml
Other drugs which contain Obiltoxaximab or a similar ingredient: (1 result)
- ANTHIM Obiltoxaximab